v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Revenues $ 329,308 $ 275,410 $ 1,228,409 $ 1,046,193
Cost of goods sold 264,959 220,309 984,038 837,883
Gross profit 64,349 55,101 244,371 208,310
Selling, general, and administrative expenses 51,344 47,168 307,291 167,364
Operating income 13,005 7,933 (62,920) 40,946
Other expenses (income):        
Interest expense 170 765 3,278 2,859
Other expense (income), net (271) 73 279 367
Total other expenses (income) (101) 838 3,557 3,226
Income before income taxes 13,106 7,095 (66,477) 37,720
Provision for income taxes 3,833 0 4,556 0
Net income (loss) 9,273 7,095 (71,033) 37,720
Less net income attributable to Guardian Pharmacy, LLC prior to the Corporate Reorganization 0 2,786 22,760 23,902
Less net income (loss) attributable to non-controlling interests (175) $ 4,309 16,254 $ 13,818
Net income attributable to Guardian Pharmacy Services, Inc. $ 9,448   $ (110,047)  
Net income per share of Class A and Class B common stock        
Basic $ 0.15      
Diluted $ 0.15      
Weighted-average Class A and Class B common shares outstanding        
Basic 62,043,311      
Diluted 62,914,077      
Class A and Class B common stock [Member]        
Net income per share of Class A and Class B common stock        
Basic [1]     $ (1.77)  
Diluted [1]     $ (1.77)  
Weighted-average Class A and Class B common shares outstanding        
Basic     62,005,811  
Diluted     62,005,811  
[1] Basic and diluted net income (loss) per share of Class A and Class B common stock is applicable only for the period from September 27, 2024 through December 31, 2024, which is the period following the initial public offering (“IPO”) and related Corporate Reorganization (as defined in Note 1 to the Consolidated Financial Statements). See Note 10 Basic and Diluted Loss Per Share for the number of shares used in the computation of net income (loss) per share of Class A and Class B common stock and the basis for the computation of net income (loss) per share.